Clinical trial

Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal…

NCT00497367 · Boston Scientific Corporation, Industry · Completed

Key facts

NCT number NCT00497367
Title Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System
Official title A Prospective, Single-arm, Multicenter 2-phase Feasibility Study to Assess the TAXUS Petal Paclitaxel-Eluting Bifurcation Coronary Stent System (TAXUS Petal)for the Treatment of de Novo Atherosclerotic Bifurcation Lesions
Lead sponsor Boston Scientific Corporation, Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions Cardiovascular Diseases
Intervention type Device
Interventions Percutaneous Coronary Intervention (PCI) TAXUS Petal
Enrollment 28
Start date Jul 1, 2007
Primary completion Jul 1, 2008
Completion Jun 1, 2013
First posted Jul 6, 2007
Last update posted Mar 26, 2015
Countries France, Germany, New Zealand

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies